EMV Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Glycotestglycotest.comJun 2026
Glycotest develops diagnostic tests for the early detection of liver disease and liver cancer.
BiotechDigital HealthHealthtechMedical DevicesMerion Station, US
Charles Swindell(Executive Officer, Director)
BoardIlian Iliev(Director)inEd Hooper(Director)inJenny Jiang(Director)
Co-investorsFosun Pharma
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.